Company intelligence / Profile preview

DND Biotech

Ownership: Private
Development stage: Commercial

Overview

DND Biotech develops innovative bio-based solutions for the remediation of contaminated soils and groundwater using biotechnological approaches such as bioaugmentation and mycoremediation. The company provides engineering services as well as proprietary technologies aimed at restoring soil fertility while safeguarding the environment and public health. Their solutions are positioned as more sustainable alternatives to conventional remediation methods.

Therapeutic areas: Other
Modalities: Microbial therapy (bioaugmentation)MycoremediationBio-based technologies
Industry: Non-Drug Biotech

Partnerships

Participates in Horizon Europe projects related to environment & natural resource management

Beyond the preview

Go deeper on DND Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DND Biotech.

Explore the full profile